A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD: Spring 2023
Thomas Abrams, MD
From the Editor's Desk
I am honored to continue my tenure as Editor in Chief of Oncology Data Advisor in 2023. The last year was a thrill for me, as the post afforded me a front-row seat to lectures, panel discussions, and podcasts from some of the most respected names in our field. I can assure you that what we have planned for 2023 is even more ambitious with multiple interview series, long-form essays, and oncology-focused podcasts available nowhere else.
A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD
Thomas Abrams, MD
From the Editor's Desk
I am thrilled to announce that I will be staying on as Editor in Chief of Oncology Data Advisor for at least another year. It gives me such great joy to work with such an accomplished group of experts in oncology, as well as with an extremely professional core of editors headed up by Keira Smith. We have grand plans for 2023. In the meantime, pleas...
A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD
Thomas Abrams, MD
From the Editor's Desk
It's been a busy three months here at Oncology Data Advisor (ODA) since I last banged out an "Editor's Notes." One of the highlights was ODA's presence at the American Society of Clinical Oncology (ASCO) Annual Meeting. Many researchers spoke on camera with us about the work they were presenting at the meeting, and visibility for the website increa...
A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD: May 2022
Thomas Abrams, MD
From the Editor's Desk
From my perch atop the masthead at Oncology Data Advisor, I am awed by the dozens of oncology professionals who give freely of their time and expertise to inform our readership of the latest in their respective areas. Their efforts are what make ODA a premier online resource for all things in this ever-evolving field. My heartfelt thanks go to thes...
A Letter to Oncology Data Advisor Readers From Thomas Abrams, MD
Thomas Abrams, MD
From the Editor's Desk
It is my pleasure to assume the post of Editor in Chief of Oncology Data Advisor for 2022. One of the perks of this role is the opportunity to speak directly to you, the readership, about everything we are up to here. Not only do we strive to give you trenchant summaries of the latest and most relevant oncology treatment breakthroughs in print, pod...

Copyright © Oncology Data Advisor. All rights reserved.